MarketsPharma & Biotech
$MRK
Merck
Stories that name Merck, newest first.
News, not investment advice.
- Biotech & Genomics82.2%Moderna and Merck's melanoma vaccine cut recurrence or death by 42%, and Moderna stock fell 17.6%
- Medicare$2,400Paying cash through Epic's new drug prices may not count toward Medicare's $2,400 cap
- Healthcare & InsuranceCentene's Gold Card vs. UnitedHealthcare and Humana
- Breakthroughs58%Amgen's Imdelltra with Imfinzi cut the risk of death by 58% in small cell lung cancer, a Phase 3 trial found
- MedicareWe checked UnitedHealth's Medicare Advantage cut against CMS files. A third of its PPO members left.
- WearablesOura and WHOOP start research studies with Abu Dhabi's health regulator
- Women's HealthTrump order tells NIH to create a Women's Health Division within 90 days
- Women's HealthFDA clears a bioMérieux vaginitis test that gives results in about 20 minutes
- Women's HealthFDA approves the first generic Climara Pro, a weekly hormone patch for menopause
- Healthcare & Insurance28%FDA proposes cadmium limits for baby food, with 10 parts per billion for most jars and pouches
- Breakthroughs52.9%FDA approves Roche's Enspryng for thyroid eye disease after one of its two trials missed
- MedicareMedicare Advantage passes 36 million members, CMS's October file shows
